[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.209.213. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1990

Cox Regression Analysis in Clinical Research

Author Affiliations

From the National Eye Institute, Biometry and Epidemiology Program, National Institutes of Health, Bethesda, Md.

Arch Ophthalmol. 1990;108(6):888-889. doi:10.1001/archopht.1990.01070080132051
Abstract

The Cox survivorship model1 has been used widely in medical research and recently in the ophthalmic literature to analyze prognosis following alternative treatments of uveal melanoma.2-5 The purpose of this short communication is to explain what Cox regression analysis is, so that investigators will understand its role in clinical research.

The Cox model is a particular type of survivorship model. More generally, survivorship models are used to describe and interpret the rate at which deaths occur over time in some population. The clinical investigator may use these models to interpret the rate at which morbid events occur as well, such as loss of vision, progression of retinopathy, and marked increase in intraocular pressure. When investigators are interested in determining how a variety of factors affect the rate at which events occur (eg, treatment, characteristics of the disease, or of the patient), they may wish to use the Cox

References
1.
Cox DR.  Regression models and life-tables . J R Stat Soc . 1972;B34:187-202.
2.
Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA, Brady LW.  Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body . Arch Ophthalmol . 1986;104:655-661.Article
3.
Gamel JW.  Ocular melanoma . Arch Ophthalmol . 1985;103:1284.Article
4.
Char DH, Phillips TL, Andejeski Y, Crawford JB, Kroll S.  Failure of preenucleation radiation to decrease uveal melanoma mortality . Am J Ophthalmol . 1988;106:21-26.
5.
Seddon JM, Gragoudas ES, Albert DM, Hsieh C-C, Polivogianis L, Friedenberg GR.  Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation . Am J Ophthalmol . 1985;99:282-290.
6.
Seigel D.  Regression . Arch Ophthalmol . 1987;105:185.Article
7.
Gass JDM.  Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas . Arch Ophthalmol . 1985;103:916-923.Article
8.
Kaplan LD, Abrams DI, Feigal E, et al.  AIDS-associated non-Hodgkin's lymphoma in San Francisco . JAMA . 1989;261:719-724.Article
9.
Podgor MJ, Cassel GH, Kannel WB.  Lens changes and survival in a population-based study . N Engl J Med . 1985;313:1438-1444.Article
10.
Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis . New York, NY: John Wiley & Sons Inc; 1980.
11.
Draper NR, Smith H. Applied Regression Analysis . New York, NY: John Wiley & Sons Inc; 1966.
×